Press Releases

Fourth Quarter Revenue Growth Ahead of Company Expectations at 9.1% RARITAN, N.J., March 18, 2021 (GLOBE NEWSWIRE) -- Ortho Clinical Diagnostics Holdings plc (Nasdaq: OCDX), one of the world's largest pure-play in-vitro diagnostics (IVD) companies, today announced financial results for the fourth
Mar 18, 2021
Former CEO of Charles Schwab Investment Management will also serve as audit committee chair RARITAN, N.J., Feb. 23, 2021 (GLOBE NEWSWIRE) -- Ortho Clinical Diagnostics (Nasdaq: OCDX), one of the world’s largest pure-play in vitro diagnostics (IVD) companies dedicated to transforming patient care,
Feb 23, 2021
Agencies Provide Stable Outlook Following Company’s Initial Public Offering RARITAN, N.J., Feb. 17, 2021 (GLOBE NEWSWIRE) -- Ortho Clinical Diagnostics Holdings plc (Nasdaq: OCDX) ("Ortho"), one of the world's largest pure-play in vitro diagnostics companies, today announced that S&P Global (“S&P”)
Feb 17, 2021
RARITAN, N.J. , Jan. 27, 2021 /PRNewswire/ -- Ortho Clinical Diagnostics Holdings plc ("Ortho"), the world's largest pure-play in vitro diagnostics company dedicated to improving and saving lives through innovative laboratory testing and blood-typing solutions, today announced the pricing of its
Jan 27, 2021
Displaying 11 - 20 of 102